SST and colorectal carcinoma: No significant differences in SST and SST1-5 (mRNA and peptide) expression were found between tumors of different Dukes’ stages, Astler–Coller classification stages B2 vs. C2, or in different clinical TNM clinical stages (II vs. III as most common in CRC patients).